» Articles » PMID: 15603057

Relevance and Necessity of Studies on Second-line Chemotherapy in Melanoma

Overview
Journal Onkologie
Specialty Oncology
Date 2004 Dec 18
PMID 15603057
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases.

Di Giacomo A, Danielli R, Guidoboni M, Calabro L, Carlucci D, Miracco C Cancer Immunol Immunother. 2009; 58(8):1297-306.

PMID: 19139884 PMC: 11030873. DOI: 10.1007/s00262-008-0642-y.